Results 81 to 90 of about 3,785 (146)

Invasive Fungal Infections After Intestine Transplantation: Epidemiology and Outcomes

Mycoses, Volume 69, Issue 5, May 2026.
ABSTRACT Background Invasive fungal infections (IFIs) represent a major complication after intestine transplantation, with reported incidence rates between 40% and 49%. These infections are associated with high morbidity and allograft loss. This study evaluates the impact of post‐transplant IFIs on graft outcomes in intestine transplant recipients ...
Mayyadah H. Alabdely, Jessica Lum, Blanca E. Gonzalez, Masato Fujiki, Zachary A. Yetmar   +4 more
wiley   +1 more source

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

Drug Design, Development and Therapy, 2012
Andreas O Doesch,1 Janika Repp,1 Nina Hofmann,1 Christian Erbel,1 Lutz Frankenstein,1 Christian A Gleissner,1 Constanze Schmidt,1 Arjang Ruhparwar,2 Christian Zugck,1 Paul Schnitzler,3 Philipp Ehlermann,1 Thomas J Dengler,4 Hugo A Katus11Department of ...
Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA   +12 more
doaj  

High burden of CMV infections after simultaneous pancreas-kidney transplantation—a nationwide cohort study

Frontiers in Transplantation
Cytomegalovirus (CMV) infections remain a common problem after solid-organ transplantation. We characterized the burden of CMV infections, and adverse events of CMV prophylaxis after simultaneous pancreas-kidney transplantation (SPK). We included all SPK
Kaisa Ahopelto, Juulia Grasberger, Fernanda Ortiz, Agneta Ekstrand, Arno Nordin, Marko Lempinen, Ilkka Helanterä   +6 more
doaj   +1 more source

Isolated Kidney Transplant in Primary Hyperoxaluria‐1 Enabled by Small Interfering RNA (siRNA) Therapy. Is It Time for Change? Case Report and Review of the Literature

Pediatric Transplantation, Volume 30, Issue 5, May 2026.
ABSTRACT Background Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder characterized by excessive oxalate production that leads to nephrocalcinosis or nephrolithiasis and progressive kidney failure, associated with systemic oxalosis that is not reversed by dialysis. Pharmacological treatment is limited.
Shameer M. Habeeb, Eva Simkova, Samhar Al‐Akash, Hazem S. Awad, Haneen Yamin, Loai A. Eid, Watfa S. Aldhaheri, Waldo Concepcion, Martin Bitzan   +8 more
wiley   +1 more source

Impact of Doxycycline Prophylaxis on Reducing Ureaplasma and Mycoplasma‐Related Complications in Lung Transplant Recipients

Transplant Infectious Disease, Volume 28, Issue 3, May/June 2026.
Doxycycline prophylaxis in lung transplant recipients was associated with reduced hyperammonemia syndrome and shorter ventilation, ICU, and hospital stays. These findings suggest that doxycycline prophylaxis may help prevent Ureaplasma/Mycoplasma‐related morbidity.
Lara Jones, Byeong Choi, Maria Velez, Stephanie Levine, Jason Gauthier, Edward Sako, Holly Keyt   +6 more
wiley   +1 more source

Cytomegalovirus prophylaxis using low-dose and ultra-low-dose valganciclovir for patients who have undergone allogeneic hematopoietic stem cell transplantation: A retrospective study

Journal of International Medical Research
Objective Cytomegalovirus reactivation is a clinically significant complication after allogeneic hematopoietic stem cell transplantation. Valganciclovir is commonly used for cytomegalovirus prophylaxis; however, the optimal dosing strategy remains ...
Wei-Hsiang Tseng, Cheng-Hsien Lin, Yu-Chen Su, Ling-Chiao Teng, Chieh‐Lin Jerry Teng   +4 more
doaj   +1 more source

Pre-Transplant Frequencies of FoxP3+CD25+ in CD3+CD8+ T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients

Transplant International
Cytomegalovirus (CMV) infection detrimentally influences graft survival in kidney transplant recipients, with the risk primarily determined by recipient and donor serostatus. However, recipient CD8+ T cells play a crucial role in CMV control. The optimal
Agnes A. Mooslechner, Agnes A. Mooslechner, Max Schuller, Verena Pfeifer, Verena Pfeifer, Konstantin A. Klötzer, Barbara Prietl, Barbara Prietl, Alexander H. Kirsch, Philipp Stiegler, Robert Sucher, Harald Sourij, Alexander R. Rosenkranz, Kathrin Eller   +13 more
doaj   +1 more source

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients

Clinical Ophthalmology, 2010
A Jayaprakash Patil1,2,3, Ashish Sharma1,4, M Cristina Kenney1, Baruch D Kuppermann11Department of Ophthalmology, Gavin S Herbert Eye Institute, University of California, Irvine, Irvine, CA, USA; 2Department of Ophthalmology, Summa Health System, Akron ...
A Jayaprakash Patil, Ashish Sharma, M Cristina Kenney, et al   +3 more
doaj  

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial

BMC Infectious Diseases, 2018
Background Cytomegalovirus (CMV) prophylaxis may prevent CMV indirect effects in renal transplant recipients. This study aimed to compare the efficacy of valganciclovir and valacyclovir prophylaxis for CMV after renal transplantation with the focus on ...
Tomas Reischig, Martin Kacer, Petra Hruba, Hana Hermanova, Ondrej Hes, Daniel Lysak, Stanislav Kormunda, Mirko Bouda   +7 more
doaj   +1 more source

Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?

Advances in Virology, 2011
The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic failure and disease progression. CMV strains resistant to ganciclovir or valganciclovir have been associated with specific mutations in the UL97 and UL54 ...
Nada Madi, Widad Al-Nakib, Alexander Pacsa   +2 more
doaj   +1 more source